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RUNNING TITLE:
Hippocampal sub-structures at 7T.

ABSTRACT

Purpose: To provide a more detailed investigation of hippocampal subfields using ultrahigh field magnetic resonance imaging (MRI) for the identification of hippocampal
pathologies in temporal lobe epilepsy.
Materials and Methods: Patients (N=13) with drug-resistant TLE (9 with HS-no, 4 HS)
and 20 age-matched healthy controls were scanned and compared using a 7T MRI
protocol. Using a manual segmentation scheme to delineate hippocampal subfields,
subfield-specific volume changes and apparent transverse relaxation rate (𝑅2∗ ) were
studied between the two groups. In addition, radiological patient assessment at 7T and
clinical outcomes were correlated with measured subfield changes.
Results: Volumetry of the hippocampus at 7T in HS patients revealed significant
ipsilateral subfield atrophy in CA1 and CA4DG. Volumetry also uncovered subfield
atrophy in 33% of HS-no patients, which had not been detected using conventional
imaging.
Conclusions: These preliminary findings indicate that hippocampal subfield volumetry
assessed at 7T may be superior to conventional (1.5T) visual inspection by a
neuroradiologist in the identification of hippocampal pathologies in TLE, however
difficulty remains in identifying HS-no cases by imaging.

KEY WORDS
Ultra-high field MR; Hippocampal subfield; Volumetry; Transverse relaxation rate;
Temporal lobe epilepsy

INTRODUCTION
Temporal lobe epilepsy (TLE) is the most common form of adult focal epilepsy. For
approximately 30% of TLE patients the condition is medically intractable (1), with
surgical treatment as the standard of care. Surgical resection of the affected region of the
brain aims to remove the seizure-inducing epileptogenic foci while excluding eloquent
cortex and pathways, crucial for sensory, motor, and linguistic function. However, less
than 50% of patients become seizure-free at 10 years after surgery (2), and there is a risk
of deficit in language, auditory, and cognitive processes from damage to surrounding
cortex and pathways (3).

The pathology of TLE most commonly manifests as hippocampal sclerosis (HS),
characterized by neuronal loss and gliosis of specific subfields of the hippocampus and
clinically by increased signal intensity on imaging (4, 5). Although lesions associated
with the epileptogenic focus, like HS, can often be identified by MRI, many of the HS-no
patients have unidentifiable lesions on conventional 1.5T MRI (6). In cases with
identifiable HS, post-operative surgical outcomes are more favourable when compared to
MRI-negative cases (4, 7–9). Furthermore, histopathological studies looking at subfield
atrophy patterns in TLE patients with HS demonstrate that patients with more extensive
subfield atrophy are more likely to become seizure free than those with more limited
neuron loss (4, 8). Hence, having pre-operative knowledge pertaining to the extent and
distribution of hippocampal neuronal loss may give insight into the prognosis of surgical
candidates, potentially affecting surgical planning.

The hippocampus is a compound temporal lobe structure of the brain traditionally divided
into the hippocampal head, body, and tail. The hippocampal body comprises structurally
and functionally distinct subregions (subfields) (10); the subiculum (SUB), ammon’s
horn (CA1-CA4), and dentate gyrus (DG). Histopathological studies have shown that
disease processes selectively affect the different morphologically and functionally
distinct subfields of the hippocampus (11, 12), for instance TLE has been characterized
by loss of tissue in the CA1, DG, and global hippocampal atrophy (13–16). To study this
further, Mueller et al. (2009) manually segmented the hippocampi of TLE patients to
demonstrate the validity of using subfield volumetry in the detection of hippocampal
atrophy at 4T MRI. In their study, regional hippocampal volume losses in CA1, CA3, and
DG, with relative sparing of CA2 was detected in TLE patients with HS defined by visual
assessment at 1.5T. Furthermore, the authors suggest the superiority of subfield
volumetry over conventional hippocampal volumetry for the detection of hippocampal
pathologies in TLE. This claim was moderately supported through the detection of
hippocampal volume losses in 17% of TLE patients without identified HS (Mueller et al.,
2009).

Clinical 1.5T and 3.0T MRI scanners have limited ability to image the internal
architecture of the hippocampus due to spatial resolution, contrast, and imaging
constraints (18). Higher field strength MRI scanners provide a gain in intrinsic MR signal
because of the linear relationship between the signal to noise ratio (SNR) and magnetic
field strength. This increased SNR can also be exploited through imaging with increased
resolution at 7T, which can consistently reveal hippocampal subfield morphometry at

300-500µm within a clinically acceptable imaging duration (19, 20). This advancement in
imaging technology gives us the capability to study minute changes in hippocampal
anatomy associated with TLE ideally suitable for clinical, in-vivo, and preoperative
analysis.

Susceptibility weighted imaging (SWI) is an MRI technique that takes advantage of
magnetic susceptibility differences between different tissues, for example blood, iron,
and calcifications. One measure of SWI is the apparent transverse relaxation rate (𝑅2∗ ).
Previous work investigated the use of susceptibility related contrast for in vivo
characterization of the hippocampal subfields at 7T and found significant differences in
𝑅2∗ across adjacent subfields (21). Therefore, this work suggests that quantitative maps
based on SWI may be superior in sensitivity for the detection of abnormalities of specific
hippocampal subfields than magnitude images and provides motivation for analysis of
subfield composition in healthy and diseased populations (21).

The study of hippocampal subfield volumetry may be superior compared to conventional
hippocampal volumetry for the detection of hippocampal pathologies in TLE.
Furthermore, the identification of HS is clinically important in predicting surgical
outcomes. In cases where gross HS is not identifiable in clinical 1.5T MRI, a more
detailed analysis of hippocampal subfields using high field MRI may reveal areas of
sclerosis. The effectiveness of ultra-high field magnetic resonance techniques in
assessing and localizing abnormal structure of the temporal lobe was studied here. This
work focused mainly on in-vivo detection of pathological TLE sub-types as the principle

objective. This goal was accomplished through the development of a normative database
of hippocampus structure using healthy volunteer 7T MRI scans. Using a manual
segmentation scheme to delineate hippocampal subfields, this normative database was
used to compare hippocampal subfield volume and 𝑅2∗ between healthy controls and TLE
patients. Subfield-specific changes in volume and 𝑅2∗ were studied and radiological
patient assessment at 7T was correlated with measured subfield changes and surgical
outcomes.

MATERIALS AND METHODS

Study Population

Thirteen patients with drug-resistant TLE were recruited from the London Health
Sciences Centre Comprehensive Epilepsy program, where they underwent continuous
video-EEG monitoring followed by anterior temporal lobectomy. All recruited patients
had preoperative investigations including neuropsychological testing and a 1.5T MRI
with epilepsy protocol. Clinical data were collected for each patient, including age at
surgery, gender, suspected epilepsy type, clinical 1.5T MRI reports, EEG reports,
subdural electrode recording reports, clinical follow-up notes post resection and
corresponding histopathology reports if applicable. This project was approved by the
Office of Research and Ethics of Western University, and informed consent was obtained
from all patients prior to their recruitment in the study. Exclusion criteria included
patients with severe coexisting medical conditions and those unsuitable for MRI

evaluation. Nine patients (mean age 31 ± 12.57, left TLE/right TLE 6/3, female/male 3/6)
had normal-appearing hippocampi on their 1.5T MR examinations (HS-no) and 4 patients
(mean age 36 ± 12.78, left TLE/right TLE 2/2, female/male 3/1) had evidence of HS on
their 1.5T MR images in visual assessment by an experienced neuroradiologist (Table 1).
The control population consisted of 20 healthy volunteers (mean age 31.2, female/male
10/10).

MRI Acquisition

Ultra-high field data were acquired on a 7 T neuroimaging optimized MRI scanner
(Agilent, Santa Clara, CA, USA/ Siemens, Erlangen, Germany) using a 16-channel
transmit- receive head coil array constructed in-house. The imaging sequences used for
this study were multi-echo gradient-echo sequences with six echoes acquired and a 0.5
mm in-plane resolution (TR=40 ms, TE1=4.57 ms, echo spacing=4.89 ms, flip
angle=13, N=1, matrix=256 x 360, 80 slices, slice thickness=1.5 mm, FOV=128
x 180 x 120 mm, total time=12 min). Slices were acquired perpendicular to the long axis
of the hippocampus in a coronal oblique orientation, in addition to a T1-weighted
MPRAGE sequence (matrix=256x512x172, resolution=0.58x0.43x1 mm, scan time =
5:42 min). These images were assigned randomized IDs assigned for visual interpretation
by the neuroradiologists. We bias-corrected the images by employing the non-uniformity
correction filter (N4) (22).

Radiological Assessment

High-resolution images acquired at 7 Tesla had mesial temporal internal architecture and
mesial temporal size graded on a 4-point scale (normal, probably normal, possibly
abnormal, and definitely abnormal) by an experienced neuroradiologist while blinded to
clinical data. This data was used and further analyzed in our previous paper currently in
submission (Kwan B, manuscript submitted). For the purpose of this study, if either
mesial temporal internal architecture or mesial temporal size was abnormal it was
designated hippocampal abnormality (HL). If both size and architecture were abnormal it
was designated hippocampal sclerosis (HS). The criteria used for classification includes
size differences (atrophy), abnormality in shape, and increased signal.

Manual Marking of Hippocampal Subfields

An ultra-high field 7T MRI protocol for manual hippocampal subfield delineation was
adapted from the 4T subfield delineation protocol proposed by (23) as well as the
Duvernoy et al. (2005) atlas (10). This method for manual hippocampal subfield
delineation was described in detail by Goubran et al., (2014) (Figure 1). Subfields were
segmented in the body of the hippocampus only, defined as 6 slices just posterior to the
head of the hippocampus. The following subregions were segmented in these 6 slices;
Subiculum (Sub), Ammon’s horn (CA1-CA3), and CA4+Dentate Gyrus (DG). The SUB
is defined as the most medial border of the temporal cortex and its border with CA1 as a
vertical line at the edge of the SUB touching the most medial border of the DG+CA4
region. The CA1/CA2 boundary is defined as the point where a noticeable decrease in

width of the CA1 subfield is observed. The overall shape of the hippocampal formation
through the body slices was determined by the course of the outer boundary of the
hippocampus and the hypointense line representing myelinated tissue in the strata
moleculare/lacunosum (SLM). The opening of subfields into the globular region of the
hippocampal formation defines the CA3/DG+CA4 border, which was specifically
identified by the continuation of a clear consistent hypointense line representing the SLM
of CA and dendrites of the molecular layer of DG, as described by (24).

With the manual segmentation protocol defined, it was implemented on 33 randomized
subjects using the ITKsnap software (25). All images were visually inspected for
accuracy and edited when necessary.

Quantitative Measurements

Using the FSL software the mean volume of each subfield was computed and used for
subsequent analysis (26).

1

The apparent transverse relaxation rate, 𝑅2∗ = 𝑇 ∗ , was calculated using a Levenberg–
2

Marquardt, least-squares fitting routine for non-linear equations. Specifically, the
following mono- exponential decay function:
𝑆(𝑇𝐸) = 𝑆0 ∙ exp(−𝑇𝐸 ∙ 𝑅2∗ )

(1)

was fit to the magnitude data on a voxel-by voxel basis. In Eq. (1), TE represents the
echo time in ms and 𝑆0 the signal intensity at 𝑇𝐸 = 50. The mean 𝑅2∗ over each subfield
area was computed and used for subsequent analysis.

Statistical Analysis

For members of the control group, the right and left hippocampi were treated separately
for the purpose of analysis. The subfield and whole hippocampal volume and 𝑅2∗ data for
each of the control hippocampi were averaged for comparison with the patient
population. Patient volume and 𝑅2∗ data were separated into ipsi- and contralateral
designations. Multivariate analyses of covariance (MANCOVAs) were performed with
ipsilateral subfield or whole hippocampal volumes as dependent variables. This analysis
addressed the question of whether subfield volume depends on the group designation
(HS, HS-no, control), when you control for age and intracranial volume (ICV). A Tukey
post hoc analyses was completed for the MANCOVAs. This was similarly repeated for
ipsilateral 𝑅2∗ and their contralateral counterparts.

Normalized z-scores were computed using the control data to compare the severity of
volume and 𝑅2∗ deviations between different subfields. The volumes were first
normalized for head size and converted into z-scores in the same manner outlined by
Mueller et al., (2009). Analyses of variance (ANOVAs) and Tukey post hoc analyses
were used to assess subfield atrophy. These z-scores were further used to identify subjectspecific patterns of change in volume or 𝑅2∗ . Additionally, the Pearson Correlation was

used to compare the radiological assessment of mesial temporal internal architecture and
mesial temporal size with the quantitative measures of subfield volume.

For patients that underwent surgical resection, outcomes were assessed using Engel
classification (27). Its correlation with subfield volume and 𝑅2∗ and radiological
assessment was determined using the Pearson Correlation.

RESULTS

7 Tesla Volumetry

A significant ipsilateral volume group effect was revealed by MANCOVA [group:
Wilks’ Lambda 0.620; F (10,88) = 2.375; p = 0.015], indicating that there were
differences between the HS, HS-no, and control groups for the CA1 (p = 0.009),
CA2+CA3 (p = 0.005), and CA4+DG (p < 0.001) ipsilateral subfields and whole
hippocampal volume (p = 0.001). Conversely, no significant contralateral volume group
effects were revealed by MANCOVA, meaning contralateral subfields or whole
hippocampal volumes were not different between the three groups. The Tukey post hoc
analyses on the ipsilateral volume showed that the HS group had significantly smaller
CA1 and CA4+DG subfields and a smaller whole hippocampus than controls (p = 0.001,
p < 0.001, p < 0.001) and HS-no patients (p = 0.013, p < 0.001, p = 0.001). There was a
trend towards an ipsilateral volume loss in CA2+CA3. Additionally, the ipsilateral

subfield and whole hippocampal volumes in the HS-no group were not different from
those in controls (Table 2).

Likewise for 𝑅2∗ , a significant ipsilateral group effect was revealed by MANCOVA
[group: Wilks’ Lambda 0.603; F (10,88) = 2.531; p = 0.010] for the CA4+DG subfield (p
= 0.001) and and the whole hippocampal 𝑅2∗ (p = 0.008) and none revealed
contralaterally. Tukey post hoc analyses of the ipsilateral HS 𝑅2∗ showed significantly
lower 𝑅2∗ in the CA4+DG subfield (p = 0.001) and the whole hippocampus (p = 0.029)
compared to controls but not significantly lower than the HS-no group. Ipsilateral
subfield and whole hippocampus 𝑅2∗ in the HS-no group were not different from those in
controls (Table 2).

After subfield-specific volume losses were found, an ANOVA was performed using the
normalized subfield volume z-scores to identify the subfields that are most affected in
TLE-HS (Figure 2). Firstly, the ANOVA revealed a significant ipsilateral subfield effect
[F(4,15) = 6.07; p = 0.004] for HS patients. This effect was limited to only the ipsilateral
side and not the contralateral or HS-no patients. An ANOVA was similarily performed
using the subfield 𝑅2∗ z-scores and revealed no ipsilateral or contralateral subfield effects
in either HS or HS-no patients. Post-hoc analyses on the normalized subfield volume zscores of HS patients revealed significantly smaller CA1 and CA4+DG z-scores
compared to the Sub subfield. The whole hippocampus z-score on the sclerotic side was
also significantly smaller than the z-score for the Sub subfield. The HS-no group showed

no significant effect for ipsi- or contralateral subfield z-scores. This indicates a selective
volume loss in these subfields (Figures 2, 3, and 4).

The normalized z-scores were used to quantify the subject-specific change in volume and
𝑅2∗ relative to the healthy control group (Table 3). This uncovered volume loss in 3 of 9
HS-no patients. One patient (#8) demonstrated evidence for severe subfield atrophy (zscore ≤ -2) in a pattern resembling that uncovered for HS patients. This patient showed
severe ipsilateral volume loss in the CA4+DG subfield and less severe losses (z-score ≤ 1) in CA1 and CA2+CA3 (Figure 3 and 4). The ipsi- and contralateral whole
hippocampal volume of this patient was also greater than one standard deviation from the
mean of the HS-no group. The two other HS-no patients (patients #9 and #11) showed
evidence for considerable contralateral CA2+CA3 subfield atrophy (z-score ≤ -1). These
patients had ipsi- and contralateral whole hippocampal volumes within the normal range
of all HS-no patients.

Radiological Assessment

The 7T images were assessed by an experienced radiologist looking specifically at mesial
temporal internal architecture and mesial temporal size. This assessment was presented in
depth in our previous paper currently in submission (Kwan B, manuscript submitted).
Briefly, 7T MRI revealed structural lesions in 6 of 9 HS-no patients (Table 4).

Quantitatively, Pearson Correlation was used to determine the relationship between the
qualitative assessment at 7T and hippocampal subfield volumetry. The radiological
assessment of mesial temporal size demonstrated greatest correlation with the normalized
volume z-scores of the CA1 and CA4+DG subfields and the whole hippocampal label,
the correlations were -0.33, -0.39, and -0.28 respectively. Similarly, the radiological
assessment of mesial temporal internal architecture had greatest correlation with the same
subfields and coefficients of -0.22, -0.25, -0.30. Although there appeared to be a trend, no
significance was achieved for any of the correlations with P >0.05.

Surgical Outcomes

Patients undergoing temporal lobe resection were monitored through follow-up to assess
their seizure control following surgery. Engel classification was assigned to each patient
following resection and a Pearson correlation was calculated to determine the relationship
between hippocampal volume at 7T and surgical outcomes. There was no significant
correlation found between Engel classification and ipsilateral whole hippocampal and
subfield volume and 𝑅2∗ (p > 0.05) using a Pearson correlation. Furthermore, there was no
significant correlation (p > 0.05) between surgical outcomes and the radiographic
assessment of hippocampal abnormality.

DISCUSSION

The higher spatial resolution provided by ultra-high-field magnetic resonance imaging
(MRI) at 7 Tesla, allowed improved signal-to-noise ratio revealing internal sub-structures
of the hippocampus, not visible at the resolution provided by 1.5 Tesla. This work aimed
to use the increased resolution for in-vivo detection of pathological TLE sub-types for the
better prediction of surgical outcomes. To this end, a normative database of hippocampal
sub-structures was developed through the manual segmentation of healthy volunteer MRI
scans at 7 Tesla. Using the normative database, pre-operative and patient-specific
analyses were made, comparing volumetric and apparent transverse relaxation rate (𝑅2∗ )
between patients with TLE and the normative database. These comparisons were made to
assess and localize structural abnormalities in the hippocampal sub-structures of TLE
patients. Characteristic atrophy patterns were found in HS patients in the ipsilateral CA1
and CA4+DG subfields, as well as ipsilateral whole hippocampal atrophy. Three of the
HS-no patients demonstrated subfield atrophy (z-score <-1) using 7T volumetry.
Furthermore, 67% of HS-no patients showed radiologist identifiable abnormality at 7T,
indicating improved identification of abnormality at higher field strength. The novel preoperative imaging techniques utilized in this project may help predict long-term surgical
outcomes by identifying sclerotic and non-sclerotic sub-types of TLE prior to surgery.
However, in this study the surgical outcomes were followed and no significant
correlation was found.

Increased resolution and improved signal-to-noise at 7 Tesla allowed the marking of
hippocampal subfields in healthy controls and TLE patients with and without HS.
Attempts at a universal hippocampal segmentation protocol have been made (28, 29),

however still debated. At the time of this study there existed no agreed upon
segmentation protocol and thus a manual segmentation protocol was employed. The
manual marking scheme used was based on details of internal structure of the
hippocampus visible on high resolution T2-weighted images at 7T. Features were chosen
that were reliably identifiable even in cases of severe sclerosis. As Mueller et. al. (2009)
uncovered, there is preservation of internal architecture at higher field strengths,
particularly 4T. A similar preservation of architecture was found at 7T in HS patents,
despite one of the main radiographic criteria for HS in clinical 1.5T MRI is signal
abnormality and loss of the internal architecture. Although the appeal of using 7T MRI is
the higher resolution it offers, it is still not sufficient to reliably and accurately identify
the boundaries of each of the hippocampal subfield. Therefore, similar to Mueller et. at.
(2009), reliable hippocampal landmarks in addition to radiographic landmarks were used
to designate the hippocampal subfields.

Volumetry of the hippocampus at 7T in HS patients revealed a characteristic pattern of
significant global ipsilateral hippocampal atrophy, restricted subfield losses in CA1 and
CA4+DG, and no significant contralateral volume losses. These results confirm those that
have been found at 3T (30) and 4T (17), histological studies (31), as well as combined
MRI-histology investigations (5) for patients with medically intractable TLE. The same
marking scheme was used to assess the 𝑅2∗ signal within the hippocampal subfields of
HS, HS-no, and control groups. Although some significant subfield reductions in 𝑅2∗ were
measured between HS and the HS-no group, it was not possible to draw conclusions

about the 𝑅2∗ signal changes in TLE at 7T from this data without significant differences
form the control group.

Not only did volumetry reveal the expected pattern of atrophy in this study but it was
observed for each subject clinically identified as having HS, therefore confirming the
clinical designation of HS. However, of note is the ability of 7T volumetry to go beyond
the clinical designation of sclerosis and identify additional cases of sclerosis in 33% of
HS-no patients in this study. Similar to the HS patients, who were characterized in this
study by CA1, CA4+DG, and trending CA2+CA3 subfield atrophy, one of the HS-no
patients (patient #8) demonstrated a near identical pattern of atrophy. This may represent
a patient with less severe HS, whose diagnosis of HS was missed on 1.5T clinical MRI.
Therefore, the resolution provided by 7T MRI may provide novel information about TLE
pathology not available by conventional imaging. The other two HS-no patients
displaying subfield atrophy (patients #9 and #11), had volume losses mainly limited to
the contralateral CA2+CA3 subfield. This difference in atrophy pattern between HS
patients and HS-no patients suggests that patients with MRI-negative epilepsy isn’t just a
less advanced form of HS TLE but is instead a different type of TLE and is a testament to
the heterogeneity of cases of MRI-negative epilepsy (6).

For this study, patients were initially classified as having HS or HS-no TLE clinically at
1.5T. Subsequently, following preoperative imaging at 7T, an experienced radiologist
judged the scans on the basis of mesial temporal internal architecture and mesial temporal
size. Blinded to the patient’s initial classification, at 7T the radiologist confirmed

abnormal internal architecture and size corresponding to clinically classified HS patients.
Patients determined to have abnormal architecture or size at 7T also had lower
quantitative volumes in a pattern similar to that revealed by volumetry, selective losses in
CA1, CA4+DG, and the whole hippocampus label. However, the correlation was not
significant. Although the superiority 7T volumetry compared to conventional 1.5T visual
assessment hasn’t been confirmed in this study, our previous work (Kwan B, manuscript
submitted) holds promise in demonstrating that radiological assessment at 7T may be
superior to conventional visual inspection by a neuroradiologist in the identification of
hippocampal pathologies in TLE. Interestingly, the visual inspection at 7T detected
abnormality in more cases of HS-no than volumetry. Visual inspection looked at features
of size difference (atrophy), abnormality in shape, and increased signal, where as
volumetry measured differences in subfield volume and 𝑅2∗ . Therefore, subfield-specific
changes in shape or intensity may provide a fruitful area for further study.

This study is limited by the inclusion of only thirteen TLE patients and thus the results
must only be taken as preliminary. Secondly, although there are gains in intrinsic MR
signal provided by higher field strength MRI scanners which result in improvements in
spatial resolution, the boundaries between many subfields can only be defined
microscopically, and thus the definitions here instead rely on geometric rules. Validation
of the subfield marking scheme using neuronal cell counts on the resected tissue is
considered future directions for improving the impact of this work. Currently only ten of
thirteen patients have undergone surgery and resection. Of this subset, HS status has been
confirmed but subfield-specific cell counts and correlation analysis still remains to be

performed. A final limitation worth mentioning, similar to that which affected Mueller et.
al. (2009), is that the hippocampal subfields were only marked in a small region of the
anterior body, thus potentially missing atrophic changes restricted to the posterior
body/tail and head of the hippocampus. Furthermore, there may be benefit in posterior
atrophic changes and comparing these changes to those seen in the anterior body as a
method of prognostication prior to surgery. It has been shown through histopathological
studies that in TLE patients with atrophy restricted to the anterior hippocampus are more
likely to benefit from surgery than those with diffuse atrophy (13).

In conclusion in these preliminary findings, 7T volumetry demonstrated hippocampal
atrophy patterns in excellent agreement with the typical patterns of atrophy identified in
histological studies and studies at lower field strengths. Subfield volumetry also
uncovered hippocampal subfield volume losses in 33% of HS-no patients, which had not
been identified conventionally. This study suggests that hippocampal subfield volumetry
or routine clinical radiological assessment by visual inspection at 7T may be superior to
conventional visual inspection by a neuroradiologist in the identification of hippocampal
pathologies in TLE, however there remains difficulty in identifying HS-no cases by
imaging.
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TABLES
Table 1. Patient Characteristics.
Patient Number Age at
surgery
1

2

3

4

5

6
7

8

9

10

11

12

13

20

32

49

45

18

24
NA

50

42

NA

31

23

NA

Gender

Hemisphere of
Seizure Onset

M

L

F

F

F

M

M
M

F

F

M

M

M

F

L

R

R

R

L
L

L

R

L

R

L

L

Age of seizure 1.5T MR Findings
onset
3

19

22

3

14

26

47

8

18

28

18

44

1.5T MR
Designation

L HS, L occipital
lobe
encephalomalacia
(remote)

L HS

L HS

L HS

R HS, L
periventricular
heterotopia
R HS

Possible R HS

Normal
Temporal
pole/gyrus rectus is
slightly smaller on
the left
Equivocal changes
inferomedially in
the left temporal
pole
Slightly increased
T2 signal in the
right hippocampus
Bifrontal
periventricular
heterotopia
Normal

Normal

Normal

R HS

R HS

HS-no

HS-no
HS-no

HS-no

HS-no

HS-no

HS-no

HS-no

HS-no

Hippocampal pathology Follow up duration Postsurgical
(Months)
outcome
Gliosis (temporal
neocortex and
amygdala), mesial
temporal sclerosis
(hippocampus)
Gliosis (temporal
neocortex), mesial
temporal sclerosis
Gliosis (temporal
neocortex), mesial
temporal sclerosis
Gliosis (temporal lobe),
mesial temporal sclerosis
Gliosis (temporal
neocortex, hippocampus
and amygdala)
Normal
No resection

Gliosis (temporal
neocortex, amygdala,
and hippocampus)
Gliosis (temporal
neocortex, amygdala,
and hippocampus)
No resection

Mild cortical dysplasia,
mild gliosis (temporal
neocortex)
Gliosis (temporal
neocortex, amygdala,
and hippocampus), focal
cortical dysplasia type Ia
(temporal neocortex)
No resection

35

I

27

I

23

II

39

I

36

I

7

I

NA

NA

36

IV

17

I

NA

NA

18

I

18

I

NA

NA

R, right; L, left; HS, hippocampal sclerosis; MR, magnetic resonance; NA, not
applicable. Post-surgical outcome classification; according to Engel’s classification of
postoperative outcomes.

Table 2: Mean and (SD) of subfield and total hippocampal volumes and 𝑅2∗ .

Units of subfield volume are in mm3. SD, standard deviation; HS, hippocampal sclerosis.
† p < 0.05 compared to controls only.
‡ p < 0.05 compared to both HS-no and control groups.

Table 3: Normalized ipsilateral z-scores for volume.
Hippocampal Subfield
Patient
Number
1
2
3
4
5
6
7
8
9
10
11
12
13

1.5T MR
Designation
L HS
L HS
R HS
R HS
HS-no
HS-no
HS-no
HS-no
HS-no
HS-no
HS-no
HS-no
HS-no

Sub
-0.44
0.02
0.46
-0.11
0.27
-1.12
0.02
-0.55
1.10
-0.14
0.45
-0.58
2.14

CA1
-1.82
-2.18
-0.02
-1.73
0.85
0.40
-0.32
-1.22
-0.06
-0.95
0.40
-0.09
1.41

HS, hippocampal sclerosis; MR, magnetic resonance.
Table 4: Radiological assessment at 7T.

CA2+CA3
-0.76
-0.70
-0.96
-1.12
2.02
0.68
1.04
-1.60
-0.88
0.15
-0.14
0.63
-0.20

CA4+DG
-2.10
-1.29
-1.05
-1.55
0.54
0.93
0.95
-2.01
0.58
0.05
0.66
1.33
0.88

WholeHipp
-1.58
-2.08
-1.31
-1.39
1.00
-0.13
-0.05
-0.65
0.39
0.66
0.84
-0.56
1.40

Patient
Number

1.5T MR
Designation

7T MR
Designation

1
2
3
4
5
6
7
8
9
10
11
12

L HS
L HS
R HS
R HS
HS-no
HS-no
HS-no
HS-no
HS-no
HS-no
HS-no
HS-no

L HS
L HS
R HS, L HL
R HS
L HS
HS-no
R HS
L HL
HS-no
R HL
L HS
HS-no

13

HS-no

R HL, L HL

7 Tesla MRI (radiological assesment)
Mesial Temporal
Mesial Temporal Size
Internal Architecture
L definitely abnormal
L definitely abnormal
R possibly abnormal
R possibly abnormal
L possibly abnormal
R probably normal
R possibly abnormal
normal
normal
R possibly abnormal
L possibly abnormal
R + L probably
normal
R possibly abnormal

L definitely abnormal
L definitely abnormal
normal
R possibly abnormal
L possibly abnormal
normal
R possibly abnormal
L possibly abnormal
normal
normal
L possibly abnormal
R + L probably
normal
L possibly abnormal

R, right; L, left; MR, magnetic resonance; HS, hippocampal sclerosis; HL, hippocampal
abnormality (if either mesial temporal internal architecture or mesial temporal size is
abnormal).

FIGURE LEGENDS
Figure 1: Segmentation scheme for manual marking of subfields. The scheme used was
based on details of internal structure of the hippocampus visible on high resolution T2weighted images at 7T. A typical example of hippocampal subfield marking on in vivo
T2-weighted 7T coronal images of a control subject. CA2-3, CA2-CA3 transition zone;
CA4&DG, CA4 and dentate gyrus; Sub, subiculum. Numbers 1-6 represents each 0.5mm
slice of the hippocampal body that was segmented. No. 1 represents the most anterior
slice and No. 6 the most posterior slice.
Figure 2: Mean and standard deviation of (A) volume and (B) 𝑅2∗ subfield z-scores for
HS (blue) and HS-no (red) patients. *Indicates p < 0.05 compared to Sub. Sub,
subiculum; WholeHipp, whole hippocampus label.
Figure 3: Line plots demonstrating subject-specific patterns of ipsilateral atrophy. Zscores were calculated and plotted with respect to each subfield for every patient and
grouped by 1.5T MRI designation. The single HS-no patient (patient # 8) demonstrating
an atrophy pattern similar to those designated HS was grouped separately. Sub,
subiculum; WholeHipp, whole hippocampus label.
Figure 4: High resolution in vivo 7T T2-weighted representative coronal images of the
hippocampal body demonstrating patterns of sclerotic change, with arrows indicating
atrophy: (A) 33-year-old control. (B) 20-year-old HS patient with CA1 and CA4+DG
volume loss and relative sparing of the other subfields. (C) 32-year-old HS patient with
severe CA1 thinning and lesser CA4+DG atrophy with relative sparing of the other
subfields. (D) 50-year-old HS-no patient with CA1 and CA4+DG volume loss (patient
#8).

FIGURES

Figure 1: Segmentation scheme for manual marking of subfields. The scheme used was
based on details of internal structure of the hippocampus visible on high resolution T2weighted images at 7T. A typical example of hippocampal subfield marking on in vivo
T2-weighted 7T coronal images of a control subject. CA2-3, CA2-CA3 transition zone;

CA4&DG, CA4 and dentate gyrus; Sub, subiculum. Numbers 1-6 represents each 0.5mm
slice of the hippocampal body that was segmented. No. 1 represents the most anterior
slice and No. 6 the most posterior slice.

Figure 2: Mean and standard deviation of (A) volume and (B) 𝑅2∗ subfield z-scores for
HS (blue) and HS-no (red) patients. *Indicates p < 0.05 compared to Sub. Sub,
subiculum; WholeHipp, whole hippocampus label.
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Figure 3: Line plots demonstrating subject-specific patterns of ipsilateral atrophy. Zscores were calculated and plotted with respect to each subfield for every patient and
grouped by 1.5T MRI designation. The single HS-no patient (patient # 8) demonstrating
an atrophy pattern similar to those designated HS was grouped separately. Sub,
subiculum; WholeHipp, whole hippocampus label.

Figure 4: High resolution in vivo 7T T2-weighted representative coronal images of the
hippocampal body demonstrating patterns of sclerotic change, with arrows indicating
atrophy: (A) 33-year-old control. (B) 20-year-old HS patient with CA1 and CA4+DG
volume loss and relative sparing of the other subfields. (C) 32-year-old HS patient with
severe CA1 thinning and lesser CA4+DG atrophy with relative sparing of the other
subfields. (D) 50-year-old HS-no patient with CA1 and CA4+DG volume loss (patient
#8).

